Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > I wonder …
View:
Post by mercedesman on Feb 24, 2024 12:01pm

I wonder …

Paradigm was quick to release two back to back updates within one week 

All good .. except their TP remained fixed. 

I wonder if they'll soon revert back to their previous targets ( closer to $4) now that most of the past reasons for downgrades to the TP have been removed. These include: 

- poor enrolment pace,  and time distance to final FDA decision

- uncertainty about Baxter's future commitment to supporting the PMX Trial 

-uncertainty about future cash in flows ( like Baxter, warrant financing, etc.) 

- uncertainty of approval ( they are now using 100%)

- time value of money. Future cash streams are being brought forward through the improving pace of enrolment and more sites 

So shouldn't the TP pendulum start to move in the opposite direction? 


MM

Comment by ChesterLives on Feb 24, 2024 12:48pm
Very matter of fact, positive and severely understated like all things Spectral.
Comment by hmmmmmmmm on Feb 24, 2024 1:25pm
That magical $4 price target that appeared in fall of 2021 if memory serves (Paradigm has scrubbed it -so it will be tough to find).   That was right after Seto's dubious ascension to CEO. Seto used to work at Paradigm you know... and the two have made serious money of Spectral (arguably the only two). Back then the float was around 230 million shares- but now Paradigm is using 404 ...more  
Comment by SimonSaid on Feb 24, 2024 1:45pm
https://www.alphaspread.com/security/tsx/edt/dcf-valuation/base-case $3.07/share CAD Not certain of the detail of the calculation; however, emotion is most likely removed.
Comment by palinc2000 on Feb 24, 2024 2:22pm
Based on 278 million shares outstanding! If  you use 400 million diluted shares then you ger 2.13 cad per share  
Comment by hmmmmmmmm on Feb 24, 2024 4:30pm
Talk about Astrology for Men. That's a 5 yr forecast built on sand.
Comment by mercedesman on Feb 24, 2024 1:46pm
You won't find me criticizing your criticisms when it comes to dilution  while some dilution is inevitable, particularly for biotechs developing new treatments... a lack of fan-fare/promotion along the way invites a lot more.  Ironically analysts exist to promote and suggest targets that hopefully catches the attention of newbies that in turn results in less dilution over time.& ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities